In vitro and in vivo functional characterization of gutless recombinant SV40-derived CFTR vectors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

In vitro and in vivo functional characterization of gutless recombinant SV40-derived CFTR vectors

Published:2009-11-05 Issue:2 Volume:17 Page:227-237
ISSN:0969-7128
Container-title:Gene Therapy
language:en
Short-container-title:Gene Ther

Author:

Mueller C,Strayer M S,Sirninger J,Braag S,Branco F,Louboutin J-P,Flotte T R,Strayer D S

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Molecular Biology,Molecular Medicine

Link

http://www.nature.com/articles/gt2009137.pdf

Reference37 articles.

1. Schwiebert EM, Benos DJ, Fuller CM . Cystic fibrosis: a multiple exocrinopathy caused by dysfunctions in a multifunctional transport protein. Am J Med 1998; 104: 576–590.

2. Southern KW . delta F508 in cystic fibrosis: willing but not able. Arch Dis Child 1997; 76: 278–282.

3. Flotte TR . Gene therapy progress and prospects: recombinant adeno-associated virus (rAAV) vectors. Gene Therapy 2004; 11: 805–810.

4. Ferrari S, Geddes DM, Alton EW . Barriers to and new approaches for gene therapy and gene delivery in cystic fibrosis. Adv Drug Deliv Rev 2002; 54: 1373–1393.

5. Driskell RA, Engelhardt JF . Current status of gene therapy for inherited lung diseases. Annu Rev Physiol 2003; 65: 585–612.

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cre Recombinase Mediates the Removal of Bacterial Backbone to Efficiently Generate rSV40;Molecular Therapy - Methods & Clinical Development;2018-06

2. Genetic Modification of the Lung Directed Toward Treatment of Human Disease;Human Gene Therapy;2017-01

3. Selectable Markers for Gene Therapy;Gene and Cell Therapy;2015-01-13

4. Gene Therapy in Cystic Fibrosis;Translating Gene Therapy to the Clinic;2015

5. Progress in Gene and Cell Therapy for Cystic Fibrosis Lung Disease;Current Pharmaceutical Design;2012-02-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3